Cite
MLA Citation
Ignace Vergote et al.. “Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.” Lancet oncology, vol. 20, no. 6, 2019, pp. 862–876. http://access.bl.uk/ark:/81055/vdc_100084768472.0x00000c